SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study of the Efficacy and Safety of SGS742 in Subjects With Mild to Moderate Alzheimer's Disease
1 other identifier
interventional
280
1 country
59
Brief Summary
The purpose of this trial is to determine the effect of a new drug, SGS742, on memory and cognition in patients with mild to moderate Alzheimer's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Apr 2004
Typical duration for phase_2
59 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2004
CompletedFirst Submitted
Initial submission to the registry
October 7, 2004
CompletedFirst Posted
Study publicly available on registry
October 8, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2007
CompletedDecember 11, 2009
February 1, 2009
3.4 years
October 7, 2004
December 10, 2009
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- to 90 years of age
- Diagnosed with mild to moderate Alzheimer's disease
- Willing caregiver
- In general good health
You may not qualify if:
- Call 1-877-MY-MEMORY and ask to be referred to a study center located near you for entry criteria information.
- Prohibited Meds:
- Alzheimer's medications (Aricept, Exelon, Remydl, Nemenda)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (59)
Unknown Facility
Phoenix, Arizona, 85013, United States
Dedicated Clinical Research
Sun City, Arizona, 85351, United States
Northwest NeuroSpecialists, PLLC
Tucson, Arizona, 85741, United States
Clinical Trials Incorporated
Little Rock, Arkansas, 72205, United States
Margolin Brain Institute
Fresno, California, 93720, United States
NervePro Research
Irvine, California, 92618, United States
Center for Neurologic Studies
La Jolla, California, 92037, United States
Neuro Therapeutics, Inc.
Pasadena, California, 91105, United States
Pacific Research Network, Inc.
San Diego, California, 92103, United States
Affiliated Research Institute
San Diego, California, 92108, United States
San Francisco Clinical Research Center
San Francisco, California, 94109, United States
Southern California Clinical Research, Inc.
San Marino, California, 91108, United States
The Mile High Research Center
Denver, Colorado, 80218, United States
Research Center for Clinical Studies, Inc.
Darien, Connecticut, 06820, United States
Unknown Facility
Stamford, Connecticut, 06902, United States
Baumel-Eisner Neuromedical Institute, Inc.
Boca Raton, Florida, 33486, United States
Bradenton Neurology, Inc.
Bradenton, Florida, 34205, United States
Brain Matters, Inc.
Delray Beach, Florida, 33445, United States
Baumel-Eisner Neuromedical Institute
Fort Lauderdale, Florida, 33321, United States
Berma Research Group
Hialeah, Florida, 33016, United States
Allied Clinical Trials, The Neurology Group
Miami, Florida, 33125, United States
Tukoi Institute for Clinical Research
Miami, Florida, 33161, United States
Baumel-Eisner Neuromedical Institute
Miami Beach, Florida, 33154, United States
Ocala Neurodiagnostic Center
Ocala, Florida, 34471, United States
Unknown Facility
Orange City, Florida, 32763, United States
Unknown Facility
Palm Springs, Florida, 33461, United States
Unknown Facility
Pompano Beach, Florida, 33064, United States
Unknown Facility
Tampa, Florida, 33613, United States
Unknown Facility
Tampa, Florida, 33647, United States
CSI Research
Decatur, Georgia, 30030, United States
DeKalb Neurology Associates, LLC
Decatur, Georgia, 30033, United States
MidAmerica Neuroscience Institute
Lenexa, Kansas, 66214, United States
Neurology Department, LSU Health Sciences Center
Shreveport, Louisiana, 71103, United States
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
SW Medical Associates
Las Vegas, Nevada, 89102, United States
Unknown Facility
Paterson, New Jersey, 08759, United States
Psychopharmacology Research Association of Princeton, P.C.
Princeton, New Jersey, 08540, United States
United Health Services Office of Clinical Trials
Johnson City, New York, 13790, United States
Unknown Facility
New York, New York, 10021, United States
Raleigh Neurology
Raleigh, North Carolina, 27607, United States
Unknown Facility
Raleigh, North Carolina, 27609, United States
Unknown Facility
Winston-Salem, North Carolina, 27103, United States
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
University Memory and Aging Center
Cleveland, Ohio, 44120, United States
Unknown Facility
Toledo, Ohio, 43623, United States
Lynn Health Science Institute
Oklahoma City, Oklahoma, 73112, United States
Oregon Center for Clinical Investigations, Inc.
Eugene, Oregon, 97401, United States
Unknown Facility
Medford, Oregon, 97504, United States
Unknown Facility
Bala-Cynwyd, Pennsylvania, 19004, United States
The Clinical Trial Center, LLC
Jenkintown, Pennsylvania, 19046, United States
RI Mood & Memory Research Institute
East Providence, Rhode Island, 02914, United States
Unknown Facility
Madison, Tennessee, 37115, United States
Senior Adults Specialty Research, Inc.
Austin, Texas, 78757, United States
Claghorn-Lesem Research Clinic, Ltd.
Bellaire, Texas, 77401, United States
Radiant Research San Antonio
San Antonio, Texas, 78229, United States
Texas Medical Research Associates, LLC
San Antonio, Texas, 78238, United States
Grayline Clinical Drug Trials
Wichita Falls, Texas, 76309, United States
Unknown Facility
Bennington, Vermont, 05201, United States
National Clinical Research, Inc.
Richmond, Virginia, 23294, United States
Related Publications (1)
Froestl W, Gallagher M, Jenkins H, Madrid A, Melcher T, Teichman S, Mondadori CG, Pearlman R. SGS742: the first GABA(B) receptor antagonist in clinical trials. Biochem Pharmacol. 2004 Oct 15;68(8):1479-87. doi: 10.1016/j.bcp.2004.07.030.
PMID: 15451390BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 7, 2004
First Posted
October 8, 2004
Study Start
April 1, 2004
Primary Completion
September 1, 2007
Study Completion
September 1, 2007
Last Updated
December 11, 2009
Record last verified: 2009-02